epigenetics
The firm said its DNA methylation testing technology could be applied to dozens of cancers and potentially some non-cancer chronic diseases.
Recent meeting presentations have offered a first look at the company's targeted methylation approach and the test's high sensitivity in early-stage cancers.
Children's Hospital LA Researcher Wins $2.8M NIH Grant for Retinoblastoma Liquid Biopsy Study
The international study will sample the aqueous humor found in children's eyes and follow participants for at least two years to monitor for cancer recurrence.
Prenetics, Dennis Lo Ink $200M Deal to Form Multi-Cancer Screening Firm
The joint venture plans to develop an epigenetics-based screening test for more than 10 types of cancers and launch sales of that test in 2027.
The company has developed a simplified method for detecting cancer DNA via methylation and sees a promising application in improving the use of immunotherapy.